pGL2-p21 promoter-Luc Citations (10)

Originally described in: CCAAT displacement protein/cut homolog recruits G9a histone lysine methyltransferase to repress transcription.
Nishio H, Walsh MJ Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11257-62. Epub 2004 Jul 21. PubMed Journal

---

Articles Citing pGL2-p21 promoter-Luc

Articles
Mutations in EBF3 Disturb Transcriptional Profiles and Cause Intellectual Disability, Ataxia, and Facial Dysmorphism. Harms FL, Girisha KM, Hardigan AA, Kortum F, Shukla A, Alawi M, Dalal A, Brady L, Tarnopolsky M, Bird LM, Ceulemans S, Bebin M, Bowling KM, Hiatt SM, Lose EJ, Primiano M, Chung WK, Juusola J, Akdemir ZC, Bainbridge M, Charng WL, Drummond-Borg M, Eldomery MK, El-Hattab AW, Saleh MA, Bezieau S, Cogne B, Isidor B, Kury S, Lupski JR, Myers RM, Cooper GM, Kutsche K. Am J Hum Genet. 2017 Jan 5;100(1):117-127. doi: 10.1016/j.ajhg.2016.11.012. Epub 2016 Dec 22. PubMed
IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21. Lui AJ, Geanes ES, Ogony J, Behbod F, Marquess J, Valdez K, Jewell W, Tawfik O, Lewis-Wambi J. Cancer Lett. 2017 Jul 28;399:29-43. doi: 10.1016/j.canlet.2017.04.005. Epub 2017 Apr 12. PubMed
Histone modifications affect differential regulation of TGFbeta- induced NADPH oxidase 4 (NOX4) by wild-type and mutant p53. Boudreau HE, Ma WF, Korzeniowska A, Park JJ, Bhagwat MA, Leto TL. Oncotarget. 2017 Jul 4;8(27):44379-44397. doi: 10.18632/oncotarget.17892. PubMed
PBK attenuates paclitaxel-induced autophagic cell death by suppressing p53 in H460 non-small-cell lung cancer cells. Park JH, Park SA, Lee YJ, Park HW, Oh SM. FEBS Open Bio. 2020 May;10(5):937-950. doi: 10.1002/2211-5463.12855. Epub 2020 Apr 14. PubMed
Murine Cytomegalovirus M25 Proteins Sequester the Tumor Suppressor Protein p53 in Nuclear Accumulations. Kutle I, Szymanska-de Wijs KM, Bogdanow B, Cuvalo B, Steinbruck L, Jonjic S, Wagner K, Niedenthal R, Selbach M, Wiebusch L, Dezeljin M, Messerle M. J Virol. 2020 Sep 29;94(20):e00574-20. doi: 10.1128/JVI.00574-20. Print 2020 Sep 29. PubMed
p33ING1b regulates acetylation of p53 in oral squamous cell carcinoma via SIR2. Li XH, Li D, Liu C, Zhang MM, Guan XJ, Fu YP. Cancer Cell Int. 2020 Aug 18;20:398. doi: 10.1186/s12935-020-01489-0. eCollection 2020. PubMed
TOPK inhibition accelerates oxidative stressinduced granulosa cell apoptosis via the p53/SIRT1 axis. Park JH, Park SA, Lee YJ, Joo NR, Shin J, Oh SM. Int J Mol Med. 2020 Nov;46(5):1923-1937. doi: 10.3892/ijmm.2020.4712. Epub 2020 Aug 27. PubMed
Nurr1 Modulation Mediates Neuroprotective Effects of Statins. Willems S, Marschner JA, Kilu W, Faudone G, Busch R, Duensing-Kropp S, Heering J, Merk D. Adv Sci (Weinh). 2022 Jun;9(18):e2104640. doi: 10.1002/advs.202104640. Epub 2022 Apr 30. PubMed
Functional investigation of a novel ANKRD11 frameshift variant identified in a Chinese family with KBG syndrome. Wei S, Li Y, Yang W, Chen S, Liu F, Zhang M, Ban B, He D. Heliyon. 2024 Mar 13;10(6):e28082. doi: 10.1016/j.heliyon.2024.e28082. eCollection 2024 Mar 30. PubMed
Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection. Centeno D, Farsinejad S, Kochetkova E, Volpari T, Gladych-Macioszek A, Klupczynska-Gabryszak A, Polotaye T, Greenberg M, Kung D, Hyde E, Alshehri S, Pavlovic T, Sullivan W, Plewa S, Vakifahmetoglu-Norberg H, Monsma FJ Jr, Muller PAJ, Matysiak J, Zaborowski MP, DiFeo A, Norberg E, Martin LA, Iwanicki M. Nutrients. 2024 Jun 9;16(12):1816. doi: 10.3390/nu16121816. PubMed

If you have published an article using this material, please email us at to have your article added to this page.